Sykon Capital LLC Pro Phase Labs, Inc. Call Options Transaction History

Sykon Capital LLC

  • $300 Billion
  • Q3 2025

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

About ProPhase Labs, Inc.

PRPH Quotes by TradingView
  • Ticker PRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 16,024,400
  • Market Cap $4.81M
  • Description
  • ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...
More about PRPH
Track This Portfolio

Track Sykon Capital LLC Portfolio

Follow Sykon Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sykon Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sykon Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email